BioMarin Pharmaceutical Inc. buy UBS Group AG
Start price
05.08.25
/
50%
€51.06
Target price
05.08.26
€98.62
Performance (%)
-4.90%
Price
22:25
€48.56
Summary
This prediction is currently active. With a performance of -4.90%, the BUY prediction for BioMarin Pharmaceutical Inc. by UBS_Group_AG is down slightly. This prediction currently runs until 05.08.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -5.167% | -5.167% |
| iShares Core DAX® | -0.681% | -4.853% |
| iShares Nasdaq 100 | -0.033% | 2.862% |
| iShares Nikkei 225® | -0.536% | -5.024% |
| iShares S&P 500 | -0.211% | 0.925% |
Comments by UBS_Group_AG for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target raised by analysts at UBS Group AG from $113.00 to $114.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by UBS_Group_AG for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€65.70
20.02.25
20.02.25
€108.05
20.02.26
20.02.26
-18.54%
21.02.26
21.02.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€62.34
30.10.24
30.10.24
€97.65
30.10.25
30.10.25
-28.01%
31.10.25
31.10.25